Pharma antitrust guidelines set for public review in China
China's antitrust regulator will soon release for public consultation a new set of guidelines for the pharmaceutical industry, reinforcing its oversight of sectors closely tied to public well-being. The draft rulebook...To view the full article, register now.
Already a subscriber? Click here to view full article